ACTRN12621001504808已完成未知
An open-label pilot trial of faecal microbiome transfer to restore the gut microbiome in anorexia nervosa
niversity of Auckland0 个研究点目标入组 17 人开始时间: 2021年11月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 16 Years 至 32 Years(—)
- 性别
- Female
入选标准
- •Participants:
- •- Biological female
- •- Age 16 – 32 years
- •- BMI 13 - 19 kg/m2
- •- formal diagnosis of anorexia nervosa by an eating disorder specialist (meets the DSM-5 criteria, 307.1)
- •- Medically stable
- •- Be able and willing to swallow treatment capsules and comply with the clinical assessments.
- •- Age 18-32 years
- •- BMI 18.5 - 25.0 kg/m2
- •- Total body fat less than or equal to 33%
- •- Healthy diet (greater than or equal to 4 portions of fruit and vegetables per day)
- •- Regular exercise (moderate to vigorous physical activity for at least 3.5 hours per week)
- •- Regular bowel habit (at least once every two days)
排除标准
- •Participants:
- •- Known allergies to food and/or common medications
- •- Use of antibiotics or probiotics in the month prior to treatment
- •- Regular oral steroid treatment or daily application of potent topical steroids extensively to the body
- •- Compromised immune system
- •-Any chronic illness affecting gut or metabolic health
- •- Thoughts of self-harm and/or suicide ideation (assessed by PHQ-9)
- •- Current or planned pregnancy during the course of the study
- •- Positive screening test for any transmissible pathogen or multi-drug resistant organism
- •- Gastrointestinal disease (e.g. inflammatory bowel disease, irritable bowel syndrome, coeliac disease, eosinophilic oesophagitis)
- •- Metabolic disorder (e.g. diabetes, metabolic syndrome, hypertension, dyslipidemia, dysglycemia)
- •- Impaired fasting glucose (>5.9 mmol/l) or elevated HbA1c (>41 mmol/mol)
- •- Asthma or eczema requiring regular prophylaxis or treatment
- •- Autism spectrum conditions
- •- Previous diagnosis of mental health issues including eating disorders
- •- Current or past history of malignancy
- •- Use of oral antibiotics or probiotics in the past 3 months
- •- Regular binge drinking (>5 standard alcoholic units/session at least once a week)
- •- Past or present use of recreational drugs, tobacco, or vaping
- •- Current or past pregnancy
- •- Overseas travel in the past 2 weeks
- •- UK residence in 1980-1996 for 6 months or longer
研究者
相似试验
招募中
Unknown
Handai FMT studyJPRN-jRCTs051220110Shimizu Kentaro10
已完成
不适用
Pilot Study of Faecal Microbiota Transplantation in Multiple Sclerosis, a Phase-1 Study10007951Multiple SclerosisMSNL-OMON48243Vrije Universiteit Medisch Centrum10
已完成
不适用
A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitisulcerative colitisJPRN-UMIN000018642Juntendo university school of medicine Department of gastroenterology50
撤回
1 期
Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host DiseaseAcute Graft Versus Host DiseaseGastrointestinal Tract Acute Graft Versus Host DiseaseSevere Gastrointestinal Tract Acute Graft Versus Host DiseaseSteroid Resistant Gastrointestinal Tract Acute Graft Versus Host DiseaseNCT04280471Jonsson Comprehensive Cancer Center
已完成
1 期
Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.Sclerosing CholangitisNCT02424175Brigham and Women's Hospital10
